Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results

Horizon Therapeutics (HZNP) PT Lowered to $162 at Goldman Sachs

May 4, 2022 3:50 PM EDT

Goldman Sachs analyst Madhu Kumar lowered the price target on Horizon Therapeutics (NASDAQ: HZNP) to $162.00 (from $169.00) while maintaining a Buy rating following earnings.

The analyst commented, "Recognizing near-term headwinds for Tepezza related to carryover from omicron delays from 1Q22 into 2Q22,... More

Horizon Therapeutics (HZNP) Tops Q1 EPS by 20c; Maintains Outlook

May 4, 2022 7:10 AM EDT

Horizon Therapeutics (NASDAQ: HZNP) reported Q1 EPS of $1.34, $0.20 better than the analyst estimate of $1.14. Revenue for the quarter came in at $885.2 million versus the consensus estimate of $874.41 million.

GUIDANCE:

Horizon Therapeutics maintains its FY2022 revenue outlook of $3.9-4 billion, versus the... More